vdphl01
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Jul 8, 2024 (NCT06527365)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07146022 | Phase 3 | Jul 25, 2025 | Veradermics, Inc. |
| NCT06972264 | Phase 3 | Mar 11, 2025 | Veradermics, Inc. |
| NCT06724614 | Phase 2/Phase 3 (Phase 3) | Nov 6, 2024 | Veradermics, Inc. |
| NCT06527365 | Phase 2 | Jul 8, 2024 | Veradermics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Veradermics, Inc. | For profit | 4 | 4 | 2 | 2024 |
1 organizations
Page 1 / 1